Remove 2018 Remove 2025 Remove Clinical Trials Remove Epilepsy
article thumbnail

A Hidden Origin Story of the CBD Craze

SMPL

CBD industry will be worth $16 billion by 2025. Cannabis that is high in CBD but extremely low in THC was made legal at the end of 2018. fast-tracked clinical trials of GW Pharmaceuticals’ 98 percent CBD drug, Epidiolex. In 2018, over 60 percent of the hemp crop in Kentucky was grown for CBD.

CBD 40
article thumbnail

Medical Cannabis Company Sunshine Coast Tikun Oceana, formerly known as Medifarm Calls In The Administrators

Cannabis Law Report

The ABC reported back in 2018. ABC report 9 January 2018. Last week, federal Health Minister Greg Hunt announced changes to regulations that would allow for medicinal cannabis exports, capitalising on what the Government estimated would be a $70 billion industry by 2025. The company linked in page is equally uniformative.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A New Treatment: CBD Oil For Autism?

Puff Puff Post

This is on par with the cost currently seen for those afflicted with ADHD and diabetes, with predictions for the cost to skyrocket further by 2025. Initially, he refused their requests due to insufficient data, however the evidence shown by a recent study done in Israel on CBD managing epilepsy was enough to sway him in the other direction.

article thumbnail

Meritas Law Firms Worldwide Article: Global Cannabis Industry: The Essential Primer

Cannabis Law Report

Some of the potential health benefits associated with THC and CBD, with and without the high, respectively, include reducing chronic pain such as from migraines or cancer, alleviating anxiety, reducing inflammation, and helping treat conditions such as epilepsy, PTSD, and glaucoma. billion in 2025, according to Grandview Research.

Law 40